Adient Selected by Duramed Pharmaceuticals as Agency of Record for Enjuvia and Synthetic Conjugated Estrogens Vaginal Cream.

PARSIPPANY, N.J. -- CommonHealth today announced that Adient, its professional advertising and promotion agency located in Wayne, has been named the professional agency of record by Duramed Pharmaceuticals Inc. for two proprietary products in women's healthcare: Enjuvia(TM) (synthetic conjugated estrogens, B) tablets, and a synthetic conjugated estrogens vaginal cream currently in late stages of development.

CommonHealth (www.commonhealth.com) is the world's leading healthcare-communications network and a WPP Group (NASDAQ/ADR: WPPGY; www.wpp.com) company.

"We're very excited to have been selected for this excellent opportunity," said Guy D. Dess, president of Adient. "We are looking forward to working with the marketing team at Duramed Pharmaceuticals to establish these outstanding brands in the marketplace and to contribute to the growth of the company."

Barr Pharmaceuticals Inc., a holding company that operates through its principal subsidiaries, Barr Laboratories Inc. and Duramed Pharmaceuticals Inc., is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals.

CommonHealth comprises Adient, Carbon, Conectics, Ferguson, HLS, MBS/Vox, Noesis, ProCom, Qi, Quantum, Solara and Xchange. The organization also has partnerships with WPP companies Einson Freeman, Enterprise IG, Mendoza Dillon, Ogilvy Healthcare and PDI.